Characterization and immunogenicity of porcine adipose-derived stem cells.
Peng Q., Starch-Jensen T., Kjærgaard B., Fink T.
Animal Study on Chronic Inflammation, published in Res Vet Sci (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Res Vet Sci (2025)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41202657
- DOI
- 10.1016/j.rvsc.2025.105954
Abstract (original English)
Adipose-derived stem cells (ASCs) hold promise in regenerative medicine due to their multipotent differentiation capacity, anti-inflammatory effects, and ability to promote tissue repair. Porcine models are increasingly used in stem cell research due to their anatomical and physiological similarities to humans. This study aimed to characterize porcine ASCs (pASCs) and evaluate their immunogenicity following allogeneic transplantation. The pASCs were isolated from abdominal subcutaneous adipose tissue of an 18-month-old donor pig, expanded in an automated bioreactor, and cryopreserved. Characterization revealed high expression of mesenchymal markers (CD29, CD44, CD90, CD105) and absence of the hematopoietic marker CD45. The pASCs exhibited robust proliferative and self-renewal capacity, and the ability to differentiate into adipogenic, osteogenic, and chondrogenic lineages. Alloantibody analysis of 18 recipient pigs over four months post-transplantation demonstrated minimal alloantibody formation. These findings confirm mesenchymal stem cell identity and low immunogenicity of large-scale expanded pASCs, supporting their potential application in regenerative medicine. However, further studies are needed to validate the long-term therapeutic efficacy of pASCs in porcine disease models.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol